Citigroup Reiterates Buy on Boston Scientific, Maintains $63 Price Target
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Joanne Wuensch has reiterated a 'Buy' rating on Boston Scientific (NYSE:BSX) and maintained a price target of $63.

August 28, 2023 | 10:23 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup's reiterated 'Buy' rating and maintained price target of $63 could positively impact Boston Scientific's stock in the short term.
Analyst ratings and price targets can significantly influence investor sentiment and stock prices. In this case, Citigroup's reiterated 'Buy' rating and maintained price target of $63 for Boston Scientific could boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100